GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, Growth/differentiation factor 15, Placental bone morphogenetic protein, Placental TGF-beta, Macrophage inhibitory cytokine 1, Prostate differentiation factor, NSAID-activated gene 1 protein, NSAID-regulated gene 1 protein, NRG-1, GDF15.

MARNGDHCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKTSLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI.

Greater than 95.0% as determined by(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

Sterile Filtered White lyophilized (freeze-dried) powder.

GDF15 is lyophilized from a sterile filtered solution containing 0.1% Trifluoroacetic Acid (TFA).

The biological activity was assessed by the inhibition of DU-145 cells and was found to be 1-2 ug/ml.

It is recommended to reconstitute the lyophilized GDF15 in sterile 18M-cm H₂O at a concentration of 100µg/ml, which can then be further diluted to other aqueous solutions.

Description

GDF15 Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated, Polypeptide chain containing 2x113 amino acids and having a molecular mass of 24.5 kDa. The GDF15 is purified by proprietary chromatographic techniques.

Stability & Storage

Storage/Stability

Lyophilized GDF15 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution GDF15 should be stored at 4°C between 2-7 days and for future use below -18°C.For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles.

MARNGDHCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKTSLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI.

Greater than 95.0% as determined by(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

Sterile Filtered White lyophilized (freeze-dried) powder.

GDF15 is lyophilized from a sterile filtered solution containing 0.1% Trifluoroacetic Acid (TFA).

The biological activity was assessed by the inhibition of DU-145 cells and was found to be 1-2 ug/ml.

It is recommended to reconstitute the lyophilized GDF15 in sterile 18M-cm H₂O at a concentration of 100µg/ml, which can then be further diluted to other aqueous solutions.

Description

Stability & Storage

Storage/Stability

Size	20 µg, 1000 µg
Estimated Lead Time	2-3 weeks
Species	Human
Accession Number	Q99988
Gene Id	9518
Protein Name / Synonyms	GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, Growth/differentiation factor 15, Placental bone morphogenetic protein, Placental TGF-beta, Macrophage inhibitory cytokine 1, Prostate differentiation factor, NSAID-activated gene 1 protein, NSAID-regulated gene 1 protein, NRG-1, GDF15.
Expressed Region	MARNGDHCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKTSLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI.
Expression System	E. coli
Purity	Greater than 95.0% as determined by(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Format	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	GDF15 is lyophilized from a sterile filtered solution containing 0.1% Trifluoroacetic Acid (TFA).
Activity	The biological activity was assessed by the inhibition of DU-145 cells and was found to be 1-2 ug/ml.
Reconstitution	It is recommended to reconstitute the lyophilized GDF15 in sterile 18M-cm H₂O at a concentration of 100µg/ml, which can then be further diluted to other aqueous solutions.
Shipping Type	Ambient temperature
Storage	-20°C

Size	20 µg, 1000 µg
Estimated Lead Time	2-3 weeks
Species	Human
Accession Number	Q99988
Gene Id	9518
Protein Name / Synonyms	GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, Growth/differentiation factor 15, Placental bone morphogenetic protein, Placental TGF-beta, Macrophage inhibitory cytokine 1, Prostate differentiation factor, NSAID-activated gene 1 protein, NSAID-regulated gene 1 protein, NRG-1, GDF15.
Expressed Region	MARNGDHCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKTSLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI.
Expression System	E. coli
Purity	Greater than 95.0% as determined by(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Format	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	GDF15 is lyophilized from a sterile filtered solution containing 0.1% Trifluoroacetic Acid (TFA).
Activity	The biological activity was assessed by the inhibition of DU-145 cells and was found to be 1-2 ug/ml.
Reconstitution	It is recommended to reconstitute the lyophilized GDF15 in sterile 18M-cm H₂O at a concentration of 100µg/ml, which can then be further diluted to other aqueous solutions.
Shipping Type	Ambient temperature
Storage	-20°C

Featured Products

Growth and Differentiation Factor 15, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Featured Products

Growth and Differentiation Factor 15, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Growth and Differentiation Factor 15, Human Recombinant

Growth and Differentiation Factor 15, Human Recombinant

Featured Products

Growth and Differentiation Factor 15, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Documents

Reviews

Ask A Question

Featured Products

Growth and Differentiation Factor 15, Human Recombinant

Product Description

Specifications

Description

Stability & Storage

Documents

Reviews

Ask A Question

Growth and Differentiation Factor 15, Human Recombinant

Growth and Differentiation Factor 15, Human Recombinant